Status:
COMPLETED
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.
Eligibility Criteria
Inclusion
- Asthma symptoms brought on by allergies
Exclusion
- Patient has any lung disease
- Currently have a sinus infection or cold symptoms
Key Trial Info
Start Date :
February 26 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2004
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00092144
Start Date
February 26 2004
End Date
June 15 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.